Carl Dambkowski Apogee Therapeutics, Inc. (APGE) insider trading activity

Shares Held (Direct Ownership) 271K

4.79% 3M change

6.17% 12M change

Total Value Held N/A

Carl Dambkowski Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 04 2025	SELL Open market or private sale	$817,500 $75.0 p/Share	10,900 Reduced 3.87%	271,108 Common Stock
Nov 05 2025	SELL Open market or private sale	$594,684 $55.14 p/Share	10,785 Reduced 3.68%	282,008 Common Stock
Nov 05 2025	BUY Exercise of conversion of derivative security	$184,251 $22.86 p/Share	8,060 Added 2.68%	292,793 Common Stock
Oct 01 2025	SELL Open market or private sale	$203,378 $39.8 p/Share	5,110 Reduced 1.76%	284,733 Common Stock
Oct 01 2025	BUY Exercise of conversion of derivative security	$54,521 $22.86 p/Share	2,385 Added 0.82%	289,843 Common Stock
Sep 03 2025	SELL Open market or private sale	$104,040 $38.18 p/Share	2,725 Reduced 1.15%	233,548 Common Stock
Aug 06 2025	SELL Open market or private sale	$102,950 $37.78 p/Share	2,725 Reduced 1.14%	236,273 Common Stock

Jul 02 2025	SELL Open market or private sale	$459,195 $45.51 p/Share	10,090 Reduced 4.05%	238,998 Common Stock
Jul 02 2025	BUY Exercise of conversion of derivative security	$168,363 $22.86 p/Share	7,365 Added 2.87%	249,088 Common Stock
Jun 04 2025	SELL Open market or private sale	$100,716 $36.96 p/Share	2,725 Reduced 1.11%	241,723 Common Stock
May 07 2025	SELL Open market or private sale	$97,418 $35.75 p/Share	2,725 Reduced 1.1%	244,448 Common Stock
Apr 02 2025	SELL Open market or private sale	$141,777 $36.73 p/Share	3,860 Reduced 1.54%	247,173 Common Stock
Mar 05 2025	SELL Open market or private sale	$48,463 $30.48 p/Share	1,590 Reduced 0.63%	251,033 Common Stock
Feb 05 2025	SELL Open market or private sale	$143,228 $40.69 p/Share	3,520 Reduced 1.37%	252,623 Common Stock
Feb 05 2025	BUY Exercise of conversion of derivative security	$18,173 $22.86 p/Share	795 Added 0.31%	256,143 Common Stock
Jan 02 2025	SELL Open market or private sale	$192,730 $47.18 p/Share	4,085 Reduced 1.57%	255,348 Common Stock
Jan 02 2025	BUY Exercise of conversion of derivative security	$31,089 $22.86 p/Share	1,360 Added 0.52%	259,433 Common Stock
Dec 11 2024	SELL Open market or private sale	$223,867 $49.31 p/Share	4,540 Reduced 1.73%	258,073 Common Stock
Dec 11 2024	BUY Exercise of conversion of derivative security	$41,490 $22.86 p/Share	1,815 Added 0.69%	262,613 Common Stock
Dec 04 2024	SELL Open market or private sale	$307,056 $46.07 p/Share	6,665 Reduced 2.49%	260,798 Common Stock
Nov 06 2024	SELL Open market or private sale	$396,100 $59.43 p/Share	6,665 Reduced 2.43%	267,463 Common Stock
Oct 02 2024	SELL Open market or private sale	$376,639 $56.51 p/Share	6,665 Reduced 2.37%	274,128 Common Stock
Sep 04 2024	SELL Open market or private sale	$318,453 $47.78 p/Share	6,665 Reduced 2.32%	280,793 Common Stock
Aug 07 2024	SELL Open market or private sale	$303,448 $41.37 p/Share	7,335 Reduced 2.49%	287,458 Common Stock
Jul 03 2024	SELL Open market or private sale	$226,191 $37.73 p/Share	5,995 Reduced 1.99%	294,793 Common Stock

Also insider at

ABIO

ARCA biopharma, Inc. Healthcare

Director

Carl Dambkowski

Chief Medical Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APGE shares.

Notify only if

Value

Insider Trading

Get notified when an Apogee Therapeutics, Inc. insider buys or sells APGE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Apogee Therapeutics, Inc.

Track Activities on APGE

Account